UK Rapid Test Consortium

The UK Rapid Test Consortium (UK-RTC) is a United Kingdom industry consortium created to produce a rapid test for COVID-19. Rapid tests are a form of COVID-19 testing technology that was originally developed from significant investment by the United Kingdom government to develop new forms of COVID-19 testing that provided advantages over existing forms such as PCR. Its members include Abingdon Health, BBI Solutions, CIGA Healthcare, Omega Diagnostics, and Oxford University.[1][2]

In 2020, the consortium developed the AbC-19 rapid test to meet UK government requirements for a rapid testing solution.[2] The government ordered 1 million of the UK-RTC's rapid tests in October 2020.[3]

Distribution

CIGA Healthcare will be responsible for assembly and distribution, and has also been awarded distribution to the US after recent FDA approval.[4]

References
  1. "rapidmicrobiology UK Begin At-Home COVID-19 Antibody Testing Programme". www.rapidmicrobiology.com. Retrieved 2020-11-13.
  2. "Industry responds to call to arms to build British diagnostics industry at scale". GOV.UK. Retrieved 2020-11-13.
  3. "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 2020-11-13.
  4. "Yorkshire developed Covid-19 test approved for use in North America".


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.